BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 19886329)

  • 21. How long can continuous ambulatory peritoneal dialysis be continued?
    Okada K; Takahashi S; Higuchi T; Kinoshita Y; Kikuchi F; Yamauchi T; Yanai M; Kuno T; Nagura Y
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):65-71. PubMed ID: 8336402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous ambulatory peritoneal dialysis with a high flux membrane.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(4):904-9. PubMed ID: 8123925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Continuous ambulatory peritoneal dialysis].
    Faller B
    Rev Prat; 1991 Apr; 41(12):1080-4. PubMed ID: 2052868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term continuous ambulatory peritoneal dialysis in diabetics.
    Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
    Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical assessment of CAPD (continuous ambulatory peritoneal dialysis) for chronic end-stage renal failure].
    Ohira S; Abe K; Kon T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):478-87. PubMed ID: 6386640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of residual renal function in patients on peritoneal dialysis.
    Lutes R; Perlmutter J; Holley JL; Bernardini J; Piraino B
    Adv Perit Dial; 1993; 9():165-8. PubMed ID: 8105915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearance of osteocalcin in adults with end-stage renal disease undergoing CAPD.
    Klein JR; Grunewald RW; Steffgen J; Franz HE
    Adv Perit Dial; 1991; 7():225-9. PubMed ID: 1680431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Continuous ambulatory peritoneal dialysis in children. 2 years' experience].
    Heller-Ackeret C; Ertelt W; Leumann EP
    Schweiz Med Wochenschr; 1982 Jun; 112(24):859-64. PubMed ID: 7051275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and adequacy of continuous ambulatory peritoneal dialysis.
    Wu G; Kim D; Oreopoulos DG
    Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S48-61. PubMed ID: 3909582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muzolimine in patients on chronic hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD).
    Bandiani G; Camaiora E; Nicolini MA; Perotta U
    Z Kardiol; 1985; 74 Suppl 2():84-7. PubMed ID: 4002809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Continuous ambulatory peritoneal dialysis (CAPD) in children and adolescents].
    Bonzel KE; Mehls O; Müller-Wiefel DE; Diekmann L; Wartha R; Ruder H; Rascher W; Schärer K
    Monatsschr Kinderheilkd; 1986 Apr; 134(4):197-204. PubMed ID: 3702890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth in children treated with continuous ambulatory peritoneal dialysis.
    Kohaut EC
    Int J Pediatr Nephrol; 1983 Jun; 4(2):93-8. PubMed ID: 6618774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
    Thomson NM; Walker RG; Whiteside G; Scott DF; Atkins RC
    Proc Eur Dial Transplant Assoc; 1979; 16():171-7. PubMed ID: 548978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Program of continuous ambulatory peritoneal dialysis and renal transplantation in insulin-dependent diabetics in the terminal stage of renal insufficiency].
    Mousson C; Tanter Y; Chalopin JM; Rifle G
    Nephrologie; 1987; 8(4):205-9. PubMed ID: 3320798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Continuous ambulatory peritoneal dialysis--an effective method of treatment in chronic renal failure].
    Opatrná S; Valenta J; Sefrna F; Opatrný K
    Vnitr Lek; 1994 Jul; 40(7):420-4. PubMed ID: 8073657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy cost and complication rate of APD and CAPD as long-term outpatient treatments for renal failure.
    King LK; Kingswood JC; Sharpstone P
    Adv Perit Dial; 1992; 8():123-6. PubMed ID: 1361767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in dialysis patients: does CAPD provide an advantage?
    Hamburger RJ; Christ PG; Morris PA; Luft FC
    Adv Perit Dial; 1989; 5():91-6. PubMed ID: 2577437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.